COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

and behaviors with regards to both disease and treatment were found to be more powerful predictors of medication adherence than sociodemographic and clinical factors in patients with COPD.

The combination medication is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to ...

COPD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for ...

The symptoms of COPD — chronic cough, shortness of breath, wheezing — can easily be mistaken for aging or ignored as ...

COPD was the underlying disease condition in 90.6% of the respondents, while asthma (5.4%), bronchiectasis (2.2%), and others (eg, lung carcinoma, lungectomy) [1.8%] were the other respiratory ...

Medically reviewed by Sanja Jelic, MD Emphysema is a chronic lung disease that occurs when the air sacs in the lungs (called ...

One in 13 Australians over the age of 40 has chronic obstructive pulmonary disease or COPD but, alarmingly, only half of them ...

As the capital and surrounding areas grapple with hazardous levels of smog, experts are raising alarm over the long-term health consequences, particularly for individuals suffering from chronic ...

According to Dr Nayar, one should avoid going out until it is necessary. In case they really need to go out, they should ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.